Proteomic and oxidative stress analysis in human brain samples of Huntington disease

被引:234
作者
Sorolla, M. Alba [1 ]
Reverter-Branchat, Gemma [1 ]
Tamarit, Jordi [1 ]
Ferrer, Isidre [2 ]
Ros, Joaquim [1 ]
Cabiscol, Elisa [1 ]
机构
[1] Univ Lleida, Dept Ciencies Mediques Basiques, IRBLLEIDA, Lleida 25008, Spain
[2] Univ Barcelona, Inst Neuropatol, Serv Anat Patol, IDIBELL Hosp Univ Bellvitge, Barcelona, Spain
关键词
Huntington disease; proteomic analysis; oxidative stress; protein carbonylation; free radicals;
D O I
10.1016/j.freeradbiomed.2008.05.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington disease (HD) is a neurodegenerative disorder caused by expansion of CAG repeats in exon I of the huntingtin gene, affecting initially the striatum and progressively the cortex. This work reports a proteomic analysis of human brain postmortem samples obtained from striatum and cortex of patients with HD compared to samples of age- and sex-matched controls. Antioxidant defense proteins that were strongly induced in striatum. but also detectable in cortex, were identified as peroxiredoxins 1, 2, and 6, as well as glutathione peroxidases 1 and 6. The activities of other antioxidant enzymes such as mitochondrial superoxide dismutase and catalase were also increased in HD. Aconitase, a protein involved in energy metabolism, showed decreased activities in striatum of HID patients. Protein carbonyls, used as markers of oxidative stress, were increased in HD. and glial fibrillary acidic protein, aconitase, gamma-enolase, and creatine kinase B were identified as the main targets. Taken together, these results indicate that oxidative stress and damage to specific macromolecules would participate in the disease progression. Also, these data Support the rationale for therapeutic strategies that either potentiate antioxidant defenses or avoid oxidative stress generation to delay disease progression. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:667 / 678
页数:12
相关论文
共 99 条
  • [1] ANDREW SE, 1993, NAT GENET, V7, P513
  • [2] Striatal glucose metabolism and dopamine D-2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease
    Antonini, A
    Leenders, KL
    Spiegel, R
    Meier, D
    Vontobel, P
    WeigellWeber, M
    SanchezPernaute, R
    deYebenez, JG
    Boesiger, P
    Weindl, A
    Maguire, RP
    [J]. BRAIN, 1996, 119 : 2085 - 2095
  • [3] EXPRESSION OF ALPHA-B-CRYSTALLIN IN HUMAN BRAIN-TUMORS
    AOYAMA, A
    STEIGER, RH
    FROHLI, E
    SCHAFER, R
    VONDEIMLING, A
    WIESTLER, OD
    KLEMENZ, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (05) : 760 - 764
  • [4] Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
    Arrasate, M
    Mitra, S
    Schweitzer, ES
    Segal, MR
    Finkbeiner, S
    [J]. NATURE, 2004, 431 (7010) : 805 - 810
  • [5] The yeast prion protein Ure2 shows glutathione peroxidase activity in both native and fibrillar forms
    Bai, M
    Zhou, JM
    Perrett, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) : 50025 - 50030
  • [6] Bartzokis G, 2000, CELL MOL BIOL, V46, P821
  • [7] Increased basal ganglia iron levels in Huntington disease
    Bartzokis, G
    Cummings, J
    Perlman, S
    Hance, DB
    Mintz, J
    [J]. ARCHIVES OF NEUROLOGY, 1999, 56 (05) : 569 - 574
  • [8] Impairment of the ubiquitin-proteasome system by protein aggregation
    Bence, NF
    Sampat, RM
    Kopito, RR
    [J]. SCIENCE, 2001, 292 (5521) : 1552 - 1555
  • [9] Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated Huntingtin
    Benchoua, A
    Trioulier, Y
    Zala, D
    Gaillard, MC
    Lefort, N
    Dufour, N
    Saudou, F
    Elalouf, JM
    Hirsch, E
    Hantraye, P
    Déglon, N
    Brouillet, E
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (04) : 1652 - 1663
  • [10] BENITEZ J, 1994, HUM GENET, V94, P563